This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Elevance Health Inc. advanced 4.2% to $390.00 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.4% to 5,916.93 and the Dow Jones Industrial Average rising 0.6% to 42,322.75.
The stock's rise snapped a two-day losing streak.
Elevance Health Inc. closed 31.2% below its 52-week high of $567.26, which the company achieved on September 3rd.
The stock outperformed some of its competitors, as UnitedHealth Group Inc. fell 10.9% to $274.35, Cigna Group rose 1.8% to $308.86, and Humana Inc. fell 1.30% to $227.47.
Trading volume totaled 2.9 million, compared to the 50-day average of 1.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 15, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。